<DOC>
	<DOCNO>NCT01779713</DOCNO>
	<brief_summary>Rational : The main danger intracranial aneurism rupture conjugate subarachnoid hemorrhage ( SAH ) occurrence . SAH severe pathology lead neurological also extra cerebral disorder . The major cause morbidity mortality develop SAH secondary development delay cerebral ischemia consecutive prolonged vasospasm cerebral artery . The understanding pathophysiological mechanism SAH complication , vasospasm frequent , essential . Vasospasm define reversible shrink artery lumen diameter subarachnoid space , begin generally 4 12 day hemorrhage . Such vasospasm could huge clinical impact lead delayed neurological ischemic deficiency 17 40 % case . Up day , mechanism involve vasospasm occurrence well describe . Disposing well-established genetics transcriptomics database along cerebral ischemia inflammation essential unravel mechanism lead vasospasm occurrence SAH patient . It enable researcher well comprehend SAH pathology elaborate efficient individualize therapeutic strategy SAH acute phase order reduce risk vasospasm occurrence . Aims : 1 ) Constitute DNA RNA Biobank via blood proof oh SAH patient 2 ) Constitute database group clinical biological data 3 ) Look genetic transcriptomic early marker via genomic approach 4 ) Correlate different marker vasospasm occurrence clinical evolution patient Study : Patients inclusion do follow admission ( D1 ) `` unité de réanimation neurochirurgicale '' Pitié-Salpètrière Hospital . After obtain informed consent , blood proof realize daily 12 day : one daily 2.5ml tube transcriptomic study single 10ml EDTA tube genetic analysis . Clinical biological follow-up perform usual . 200 patient initially include 2 3 year transcriptomic study 1/3 develop vasospastic complication . The transcriptomic study thus perform compare patient develop develop complication Expected Results : Unravel vasospasm early genetic marker .</brief_summary>
	<brief_title>Transcriptomic Signature Vasospasm Consecutive Sub-arachnoid Aneurismal Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<criteria>Patient enter neurosurgical unit 48 hour follow aneurismal subarachnoid hemorrhage treat 96 first hour ( embolization surgery ) Aged 18 Caucasian origin Affiliated social care service Having ( one relate comatose ) give informed consent Subjects social care protection Subjects ( one relate comatose ) refuse sign consent Subjects protective juridical system adult</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Aneurysmal subarachnoid hemorrhage</keyword>
	<keyword>Vasospasm</keyword>
	<keyword>Transcriptomic</keyword>
	<keyword>Case-Control Study</keyword>
</DOC>